Semaglutide is commonly used as a reference compound in in-vitro GLP-1 receptor-binding assays, comparative incretin agonist studies, and receptor-signaling characterization alongside Tirzepatide and Retatrutide
We are a licensed U.S
GHK-Cu treatment reduced reactive oxygen species (ROS) production, increased superoxide dismutase (SOD) activity, and decreased TNF- and IL-6 production by inhibiting NF-B p65 and p38 MAPK signaling in LPS-induced macrophages and ALI models
Calcitonin, available in synthetic form, treats Pagets disease of bone and provides an alternative treatment option for osteoporosis
Sikiric, P., Boban Blagaic, A., Strbe, S., Beketic Oreskovic, L., Oreskovic, I., Sikiric, S., Staresinic, M., Sever, M., Kokot, A., Jurjevic, I., Matek, D., Coric, L., Krezic, I., Tvrdeic, A., Luetic, K., Batelja Vuletic, L., Pavic, P., Mestrovic, T., Sjekavica, I.,